Epitogenesis, Inc

EpitoGenesis Inc., founded in 2008 by Ms. Shohre Golestani, is a biotechnology company specializing in the development of all-natural immune-enhancing adjuvants and delivery systems for both prophylactic and therapeutic vaccines. The company's innovative technology leverages a patented micro-emulsion formulation combining three dietary supplement food-grade molecules to enhance immune responses while emphasizing safety and minimizing side effects associated with vaccinations.

With a commitment to addressing the challenges of vaccine development, EpitoGenesis has garnered four SBIR awards totaling $886K and boasts a team of experts, including notable figures such as Nobel Prize laureate Sir Michael Houghton and Dr. Jan Holmgren. Their passion for creating meaningful change fuels their mission to provide advanced solutions in the biotechnology arena, contributing to the significant impact of vaccines as cost-effective medical interventions.

Generated from the website